Clinical Trial Update: CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of CerviPrep delivering topical gemcitabine to the cervix for primary cervical, endometrial, or ovarian epithelial cancers; trial complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Ovarian Epithelial Cancer

Drugs mentioned

• CerviPrep (gemcitabine (topical formulation))

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Cervical Cancer, Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-06-17